Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quest Diagnostics
(NY:
DGX
)
151.38
+1.69 (+1.13%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Quest Diagnostics
< Previous
1
2
Next >
Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy
July 18, 2024
From
Lisata Therapeutics, Inc.; Quest Diagnostics, Haystack Oncology
Via
GlobeNewswire
Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
June 18, 2024
Myriad Genetics Inc. (NASDAQ: MYGN) is a leader in genetic testing and precision medicine. The company offers a wide variety of genetic tests including
Via
MarketBeat
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
April 30, 2024
Via
AB Newswire
Making Connections To Care: Quest Supports Inspiring Health Equity Event Hosted by Sisters on the Vineyard
August 28, 2023
Via
ACCESSWIRE
LifeMD Shares Come Back to Life on GLP-1 Business Growth
March 19, 2024
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024
Via
MarketBeat
Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing
January 09, 2024
From
Ultima Genomics
Via
Business Wire
Quest Diagnostics Inc. (NYSE: DGX) Highlighted for Surprising Price Action
December 12, 2023
Via
Investor Brand Network
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
October 17, 2023
EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END
Via
FinancialNewsMedia
Exact Sciences Serves Investors Exactly What They Wished For
May 15, 2023
Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The
Via
MarketBeat
UiPath is a Cheaper and More Profitable AI Stock
April 06, 2023
With the mainstream popularity of ChatGPT, artificial intelligence (AI) has been all the rage in 2023. The AI wars between Microsoft Co. (NASDAQ: MSFT) invest
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Quest Diagnostics Inc. (NYSE: DGX) Making Surprising Moves in Friday Session
March 24, 2023
Via
Investor Brand Network
DermTech and Sonora Quest Laboratories Expand Access to Innovative Melanoma Detection Test
November 15, 2022
From
DermTech, Inc.
Via
Business Wire
Here’s Why Quest Diagnostics Stock Should Be in Your Portfolio
October 31, 2022
Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been trading within a boxed range from $126 to $146 for the majority of 2022.
Via
MarketBeat
Exposures
COVID-19
Achievers and Quest Diagnostics Win Gold in the 2022 Brandon Hall Group Excellence Technology Awards
September 14, 2022
From
Achievers
Via
Business Wire
Rite Aid and Quest Diagnostics Expand Access to COVID-19 PCR Testing Nationwide
July 19, 2022
From
Rite Aid Corporation
Via
Business Wire
Quest Diagnostics CHRO Receives "CHRO Lifetime Achievement Award"
June 07, 2022
SOURCE: Quest Diagnostics
Via
3BL Media
Exposures
COVID-19
ConferMED Awarded Grant From the Quest Diagnostics Foundation To Provide Specialty eConsults to Front Line Providers at Federally Qualified Health Centers in Key Regions
June 03, 2022
SOURCE: Quest Diagnostics
Via
3BL Media
Quest for Health Equity Offers No Cost Wellness Screenings at Baltimore Community Event
June 01, 2022
SOURCE: Quest Diagnostics
Via
3BL Media
Quest Diagnostics Incorporated (NYSE:DGX) Shareholder Notice: Investigation over Potential Wrongdoing
May 12, 2022
San Diego, CA -- (SBWIRE) -- 05/12/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Quest Diagnostics Incorporated.
Via
SBWire
Quest Diagnostics Announces Organizational Changes to Accelerate Growth and Drive Operational Excellence
April 21, 2022
SOURCE: Quest Diagnostics
Via
3BL Media
Quest Diagnostics Incorporated (NYSE:DGX) Investor Notice: Investigation over Possible Securities Laws Violations
March 23, 2022
San Diego, CA -- (SBWIRE) -- 03/23/2022 -- Quest Diagnostics Incorporated was under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
FORTUNE Magazine Names Quest Diagnostics One of 2022 "World's Most Admired Companies" For Eighth Consecutive Year
February 03, 2022
SOURCE: Quest Diagnostics
Via
3BL Media
Development of Novel Innovative Diagnostic tests Generating Huge Revenue Opportunity for Global Blood Testing Market
February 16, 2022
Palm Beach, FL – February 16, 2022 – FinancialNewsMedia.com News Commentary – The global blood testing market has grown during the pandemic and is expected to continue to rise in the coming years....
Via
FinancialNewsMedia
Exposures
COVID-19
Walmart and Quest Diagnostics Empower People to Take Control of Their Healthcare Through New Consumer-Initiated Laboratory Testing Solution Powered by QuestDirect™ Through Walmart.com
February 02, 2022
SOURCE: Quest Diagnostics
Via
3BL Media
Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation's Corporate Equality Index for Sixth Consecutive Year
January 31, 2022
SOURCE: Quest Diagnostics
Via
3BL Media
Project HOPE Awarded Grant to Reduce Transmission of COVID-19 Variants in Long-term Care Facilities
January 26, 2022
SOURCE: Quest Diagnostics
Via
3BL Media
Exposures
COVID-19
Quest Diagnostics Earns Gold Status in American Heart Association's 2021 Workplace Health Achievement Index
December 16, 2021
SOURCE: Quest Diagnostics
Via
3BL Media
Quest Announces Annual Sustainability Awards
December 08, 2021
SOURCE: Quest Diagnostics
Via
3BL Media
Topics
Emissions
Exposures
COVID-19
Quest Provides Needed Support for Global Anti-Hate Summit
December 03, 2021
SOURCE: Quest Diagnostics
Via
3BL Media
Exposures
COVID-19
Rising Cases of Early-Onset Colorectal Cancer Calls for Expanded Biotech Screening Methods
December 01, 2021
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – December 1, 2021 – Early onset colorectal cancer is currently on the rise [[1]], according to a new study [[2]] from the...
Via
FinancialNewsMedia
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.